Tom was appointed Managing Director, Direct Investments in June 2024.
Tom brings more than 15 years’ experience and joined British Patient Capital in 2019. He helped set up its direct investment function and completed Quantexa and Thought Machine as its first direct investments – both of which are now unicorns. Previously he was at Foresight Group and was an investment manager at EcoMachines Ventures. He also co-founded a biotech manufacturing start-up Puridify, which was subsequently sold to GE Healthcare. He began his career in investment banking at Deutsche Bank.